Literature DB >> 7714095

Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids.

J Broide1, R Soferman, S Kivity, A Golander, G Dickstein, Z Spirer, Y Weisman.   

Abstract

The aim of the present study was to examine the use of low-dose ACTH-(1-24) stimulation for assessment of adrenal function and the detection of mild adrenal insufficiency. The criteria for normal response to ACTH-(1-24) are a peak cortisol level of more than 500 nmol/L (18.1 micrograms/dL) and an increment of the cortisol level above the basal one of more than 200 nmol/L (7.2 micrograms/dL). These criteria were satisfied by 32 of 33 healthy children and adults subjected to an ACTH-(1-24) dose 500 times lower (0.5 micrograms/1.73 m2) than the dose of 250 micrograms in the standard test. At 20 min, the peak cortisol level was the same in the low-dose test [(621 +/- 28 nmol/L) (22.5 +/- 1.0 microgram/dL)] as in the standard ACTH test [(654 +/- 31 nmol/L) (23.7 +/- 1.1 microgram/dL)]. Of 46 asthmatic patients who had been treated with inhaled beclomethasone dipropionate (482 +/- 42 micrograms/m2 daily; n = 32) or budesonide (507 +/- 62 micrograms/m2 daily; n = 14) for over 6 months, 16 (35%) failed to reach a cortisol peak of more than 500 nmol/L (18.1 micrograms/dL) following stimulation with 0.5 micrograms ACTH-(1-24)/1.73 m2. Of these, 11 (24%) showed a cortisol increment of less than 200 nmol/L (7.2 micrograms/dL). These 16 patients, showing insufficient response to low-dose ACTH-(1-24), also had a significantly lower (P < 0.01) mean 24-h urinary free cortisol excretion [(71 +/- 10 nmol/m2.24 h) (25.7 +/- 3.6 micrograms/m2.24 h)] than patients who responded normally [(118 +/- 11 nmol/m2.24 h) (42.8 +/- 4.0 micrograms/m2.24 h). Nonetheless, all but one of the poor responders to a 0.5 microgram ACTH showed normal stimulation with the standard 250 micrograms ACTH test. Therefore, it appears that a low-dose ACTH test is capable of revealing mild adrenal insufficiency, which is not detected by the standard high-dose ACTH test.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7714095     DOI: 10.1210/jcem.80.4.7714095

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  34 in total

Review 1.  Clinical usefulness of the low dose ACTH test.

Authors:  L Patel; P E Clayton
Journal:  J Endocrinol Invest       Date:  1999-05       Impact factor: 4.256

2.  The role of the low dose ACTH test in the evaluation of central hypoadrenalism.

Authors:  B Ambrosi; L Barbetta
Journal:  J Endocrinol Invest       Date:  1999-06       Impact factor: 4.256

3.  Repetitive graded ACTH stimulation test for adrenal insufficiency.

Authors:  T S Huang; Y D Jiang
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 4.256

4.  Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate.

Authors:  A J Drake; R J Howells; J P H Shield; A Prendiville; P S Ward; E C Crowne
Journal:  BMJ       Date:  2002-05-04

Review 5.  Inhaled corticosteroids in childhood asthma: long-term effects on growth and adrenocortical function.

Authors:  Alessandro Salvatoni; Elena Piantanida; Luana Nosetti; Luigi Nespoli
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 6.  Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids.

Authors:  B J Lipworth; J R Seckl
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

7.  Measuring systemic effects of inhaled beclomethasone.

Authors:  O Jolobe
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

8.  Fluticasone propionate 750 micrograms/day versus beclomethasone dipropionate 1500 micrograms/day: comparison of efficacy and adrenal function in paediatric asthma.

Authors:  D Fitzgerald; P Van Asperen; C Mellis; M Honner; L Smith; G Ambler
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

9.  Evidence of hypothalamic-pituitary-adrenal axis suppression during moderate-to-high-dose inhaled corticosteroid use.

Authors:  Ozlem Cavkaytar; Dogus Vuralli; Ebru Arik Yilmaz; Betul Buyuktiryaki; Ozge Soyer; Umit M Sahiner; Nurgun Kandemir; Bulent E Sekerel
Journal:  Eur J Pediatr       Date:  2015-08-09       Impact factor: 3.183

10.  Prevalence of occult adrenal insufficiency and the prognostic value of a short corticotropin stimulation test in patients with septic shock.

Authors:  Muzaffar Maqbool; Zafar Amin Shah; Fayaz Ahmad Wani; Abdul Wahid; Shaheena Parveen; Arjumand Nazir
Journal:  Indian J Crit Care Med       Date:  2009 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.